BioReperia helps every cancer patient to get the most effective treatment available, for their specific disease.BioReperia has developed a unique zebrafish tumor xenograft (ZTX™) platform that provides functional in-vivo data to evaluate treatment efficacy for tumor regression and metastasis inhibition in only 5 days.Our goal is to increase the speed and accuracy of preclinical drug development and clinical cancer treatment, enabling researchers and clinicians to select the drugs/drug candidates with the highest potential to succeed in less time.